Phân tích hoạt động cung ứng thuốc tại Bệnh viện Sản - Nhi Tỉnh Quảng Ngãi, năm 2024
Keywords
Abstract
Objective: To analyze the drug supply system at Quang Ngai Obstetrics and Pediatrics Hospital (hospital) in 2024.
Subjects and Methods: The study employed a retrospective descriptive design, analyzing data from the hospital's 2024 drug formulary, infrastructure, equipment, and drug supply management records.
Results: In 2024, the hospital fully implemented all stages of the drug supply cycle, including selection, procurement through bidding, storage, distribution, and utilization monitoring. The drug formulary comprised 346 items across 23 pharmacological groups, with anti-infective and antiparasitic drugs accounting for the largest proportion (27.46%), consistent with the hospital’s disease profile. Locally manufactured medicines represented 60.98% of the formulary, contributing to cost savings. Procurement was conducted under centralized bidding regulations, with a total expenditure of approximately 16.5 billion VND. The application of information technology effectively supported the management of bidding records and contract appendices. Storage and distribution activities complied with Good Storage Practice (GSP) standards in accordance with Circular No. 36/2018/TT-BYT. The ABC/VEN analysis revealed that the majority of the budget (84.29%) was allocated to essential medicines in the A-V and A-E categories, while non-essential drugs accounted for only 3.25%. In addition, the pharmacovigilance system recorded five serious adverse drug reactions associated with ceftazidime, indicating that drug safety monitoring was carried out rigorously.
Conclusion: The study indicates that the hospital in 2024 was organized in a comprehensive manner and complied with current regulations. The drug formulary was aligned with the hospital’s morbidity pattern, while procurement,
storage, and distribution were strictly managed, with information technology effectively applied in record management.
These factors contributed to ensuring drug availability, optimizing budget utilization, and improving the quality of patient
care.